Table of Contents: 2013 MAY–JUNE No. 392
Willis SR. NLM Classification 2013 Edition. NLM Tech Bull. 2013 May-Jun;(392):e1.
The NLM Classification, available online at //www.nlm.nih.gov/class/, incorporates all additions and changes to the schedules and index from April 2012 through March 2013. The PDF version will be updated with 2013 classification data by the end of May 2013.
The QU (Biochemistry. Cell Biology and Genetics) schedule was the major area of focus for the 2013 edition.
With the 2013 edition:
In addition:
Thirty-two (32) new class numbers were added. No class numbers were canceled.
New Number | Class Name | Former Number in the Index |
---|---|---|
QU 45 |
Macromolecular substances (General or not elsewhere classified) |
None |
QU 55.95 |
Protein engineering |
QU 450; QZ 52 |
QU 78 |
Glycosides |
QU 75 |
QU 81 |
Monosaccharides |
QU 75 |
QU 85.6 |
Lipid metabolism (General or not elsewhere classified) |
QU 85 |
QU 91 |
Prostaglandins |
QU 90 |
QU 102 |
Biological factors |
None |
QU 130.2 |
Metals (General or not elsewhere classified) |
QU 130 |
QU 130.4 |
Minerals |
QU 130 |
QU 145.3 |
Nutritional requirements |
QU 145 |
QU 145.7 |
Nutrition policy (Table G) |
QU 145 |
QU 145.72 |
[Nutrition policy] General coverage (Not Table G) |
QU 145 |
QU 460 |
Genomics |
QU 58.5 |
QU 465 |
Molecular medicine |
None |
QU 550 |
Genetic techniques (General or not elsewhere classified) |
QU 450; QZ 52; WB 60 |
QU 550.5 |
Specific techniques, A-Z |
None |
QU 550.5.C4 |
Chromosome mapping |
QU 450; QZ 52 |
QU 550.5.C5 |
Cloning |
QU 450; QZ 52 |
QU 550.5.D6 |
DNA fingerprinting |
QU 450 |
QU 550.5.G4 |
Gene expression profiling |
QU 450; QZ 52 |
QU 550.5.G47 |
Genetic engineering |
QU 450; QZ 52; WB 60 |
QU 550.5.M8 |
Mutagenicity tests |
QU 450; QZ 52 |
QU 550.5.P6 |
Polymerase chain reaction |
QU 450 |
QU 560 |
Genetic therapy |
QZ 52 |
QV 56 |
[Pharmaceutical preparations] Adverse effects (General) |
QZ 42 |
QV 58 |
Drug overdose. Prescription drug misuse |
QZ 42 |
W 76.1 |
[Health manpower and services, distribution and characteristics] General coverage (Not Table G) |
W 76 |
W 81 |
Medical tourism |
None |
WA 289 |
Consumer protection and product safety (General) |
WA 288 |
WN 195 |
Optical imaging |
None |
WR 670 |
[Skin] Surgery |
WR 650 |
WS 220 |
Palliative care. Terminal care |
WS 200 |
All index entries pertaining to the aforementioned schedule additions and changes were modified.
One hundred and eight (108) new index entries were created of which forty (40) are from the 2013 MeSH; the remainder are MeSH terms from previous years. All main index headings are now linked to the 2013 vocabulary in the MeSH Browser.
New Index Term |
1 ABO Blood-Group System -- WH 420 |
2 Administration, Intravenous -- WB 354 |
3 Ageism |
4 Arterial Pressure -- WG 106 |
5 Autacoids |
6 Autophagy -- QU 375 |
7 Binge Drinking -- WM 274 |
8 Biochemical Processes -- QU 34 |
9 Biological Factors -- QU 102 |
10 Biomarkers, Pharmacological -- QV 745 |
11 Biometric Identification -- W 786 |
12 Boron Neutron Capture Therapy -- QZ 269 |
13 Butyrates -- QU 90 |
14 Cardiac Imaging Techniques -- WG 141 |
15 Cell Adhesion -- QU 375 |
16 Cell Lineage |
17 Cell Physiological Processes -- QU 375 |
18 Chemical Safety |
19 Chitosan -- QU 83 |
20 Community Integration |
21 Controlled Substances -- QV 55-57 |
22 Coronary Angiography -- WG 141.5.A3 |
23 Deoxy Sugars -- QU 75 |
24 DNA Helicases -- QU 137 |
25 DNA, Fungal -- QW 180 |
26 Dermatologic Surgical Procedures -- WR 670 |
27 Device Approval -- WA 289 |
28 Diagnostic Test Approval -- WA 289 |
29 Drug Overdose |
30 Elder Nutritional Physiological Phenomena -- WT 115 |
31 Exocytosis -- QU 375 |
32 Fertility Preservation |
33 Food Quality |
34 Gene Expression Regulation, Plant -- QK 981-981.7 |
35 Gene Regulatory Networks -- QU 470 |
36 Gene Targeting -- QU 550 |
37 Gene Transfer Techniques -- QU 550 |
38 Genes, BRCA1 -- WP 870 |
39 Genes, BRCA2 -- WP 870 |
40 Genocide |
41 Genome -- QU 470 |
42 Genome, Bacterial -- QW 51 |
43 Genome, Plant -- QK 981-981.7 |
44 Genome, Viral -- QW 160 |
45 Geography, Medical -- WB 700-720 |
46 Health Impact Assessment -- W 84.4 |
47 Health Information Management |
48 Health Information Systems |
49 Health Services for Transgendered Persons -- WA 300-395 |
50 Homophobia -- HQ 76.4-.45 |
51 Immunoglobulins, Intravenous -- QW 601 |
52 Inappropriate Prescribing -- QV 748 |
53 Inflammation Mediators -- QV 247 |
54 Inventions |
55 Ion Channel Gating -- QU 55.7 |
56 Macromolecular Substances |
57 Magnetic Resonance Angiography |
58 Mandibular Reconstruction -- WU 600-610 |
59 Maternal Death -- WQ 270 |
60 Mechanotransduction, Cellular -- QU 375 |
61 Medical Tourism |
62 Molecular Medicine -- QU 465 |
63 Motivational Interviewing -- WM 55 |
64 Multienzyme Complexes -- QU 135 |
65 Mutagenesis, Insertional -- QU 55.95 |
66 Narrative Therapy -- WM 420.5.N3 |
67 Neurotology -- WV 21 |
68 Ochratoxins -- QW 630.5.M9 |
69 Optical Imaging -- WN 195 |
70 Organophosphate Poisoning -- QV 627 |
71 Organophosphonates -- QU 131 |
72 Pathologic Processes -- QZ 140 |
73 Pathology, Molecular -- QZ 50 |
74 Peptide Biosynthesis -- QU 68 |
75 Peroxisomes -- QU 350 |
76 Personal Narratives |
77 Personal Narratives as Topic |
78 Phosphorous Acids -- QV 138.P4 |
79 Physical Therapist Assistants -- WB 460 |
80 Prescription Drug Misuse |
81 Prostate-Specific Antigen -- WJ 762 |
82 Proteome -- QU 460 |
83 Public Health Surveillance -- WA 950 |
84 RNA Interference -- QU 58.7 |
85 Racism -- HT 1503-1595.22 |
86 Radionuclide Ventriculography -- WG 141.5.R3 |
87 Receptor, Insulin -- WK 820 |
88 Receptors, Chemokine -- QU 55.7 |
89 Receptors, Cytoplasmic and Nuclear -- QU 55.2 |
90 Receptors, G-Protein-Coupled -- QU 55.7 |
91 Receptors, Serotonin -- QV 126 |
92 Retroelements -- QU 470 |
93 Rotator Cuff -- WE 810 |
94 Sexism -- HQ 1237-1237.5 |
95 Sialic Acids -- QU 84 |
96 Solid Waste -- WA 778-788 |
97 Somatomedins -- QU 107 |
98 Spinal Cord Stimulation |
99 Telomerase -- QU 141 |
100 Telomere -- QU 470 |
101 Terminology as Topic -- W 15 |
102 Tobacco Products |
103 Tomography, Optical -- WN 206 |
104 Transgendered Persons |
105 Tumor Necrosis Factors |
106 Vascular Access Devices -- WG 26 |
107 Waste Water -- WA 778-788 |
108 Water Resources -- WA 675-690 |
Numerous main index entries and cross references were modified to reflect changes in the MeSH vocabulary. For example,
To learn more about the NLM Classification see the Fact Sheet.
By
Sharon R. Willis
Cataloging Section, Technical Services Division